Long Term Follow up Study on a Large Group of Patients with Congenital Factor XIII Deficiency Treated Prophylactically with Fibrogammin P®

Factor XIII deficiency (FXIIID) is an extremely rare hemorrhagic disorder with a prevalence of 1/3-5 million. Management of disease is performed by fresh frozen plasma (FFP), Cryoprecipitate (CP) or FXIII concentrate (Fibrogammin P®). Our objective was to assess safety and effectiveness of Fibrogamm...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Iran J Pharm Res
Main Authors: Naderi, Majid, Karimi, Mehran, Hosseini, Maryam Sadat, Moradi, Es′hagh, Shamsizadeh, Morteza, Dorgalaleh, Akbar
Format: Artigo
Jezik:Inglês
Izdano: Shaheed Beheshti University of Medical Sciences 2016
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5018293/
https://ncbi.nlm.nih.gov/pubmed/27642336
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki